Pharmacodynamics of prasugrel versus clopidogrel in Japanese patients with stable coronary artery disease (CAD) undergoing elective PCI

Trial Profile

Pharmacodynamics of prasugrel versus clopidogrel in Japanese patients with stable coronary artery disease (CAD) undergoing elective PCI

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2012

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Aug 2011 New trial record
    • 28 Jul 2011 Results presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top